MASÁROVÁ, Lucia, Jan NOVÁK, Martin PEŠL, Jiří ONDRÁŠEK, Jiří SEMÉNKA, Eva ŠIMAROVÁ and Roman PANOVSKÝ. Reccurent thrombus in the gigantic left atrium during effective anticoagulant therapy: case report. BMC Cardiovascular Disorders. London: Biomed Central Ltd, 2020, vol. 20, No 1, p. 1-7. ISSN 1471-2261. Available from: https://dx.doi.org/10.1186/s12872-019-01279-1.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Reccurent thrombus in the gigantic left atrium during effective anticoagulant therapy: case report
Authors MASÁROVÁ, Lucia (703 Slovakia, guarantor, belonging to the institution), Jan NOVÁK (203 Czech Republic, belonging to the institution), Martin PEŠL (203 Czech Republic, belonging to the institution), Jiří ONDRÁŠEK (203 Czech Republic), Jiří SEMÉNKA (203 Czech Republic, belonging to the institution), Eva ŠIMAROVÁ and Roman PANOVSKÝ (203 Czech Republic, belonging to the institution).
Edition BMC Cardiovascular Disorders, London, Biomed Central Ltd, 2020, 1471-2261.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.298
RIV identification code RIV/00216224:14110/20:00115362
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1186/s12872-019-01279-1
UT WoS 000517566900001
Keywords in English Cardiac magnetic resonance; Echocardiography; Atrial fibrillation; Recurrent thrombus; Gigantic left atrium; Anticoagulant therapy
Tags 14110115, 14110116, 14110513, 14110515, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 20/3/2020 11:40.
Abstract
Background Gigantic left atrium is defined in the current literature as an excessive dilatation of the left atrium above 65mm. Chronic mitral valve disease is associated with the development of thrombus in the left atrium in up to 19% of all cases of mitral insufficiency and appropriate treatment must be initiated to prevent thromboembolic events. In order to diagnose thrombi in the left atrium or left atrial appendage, various imaging methods may be used, including cardiac magnetic resonance. Case presentation The case report describes a 73-year-old male who developed recurrent sessile thrombus on the posterior wall of the gigantic left atrium. A large thrombus was first detected following mitral valve surgery despite effective vitamin K antagonist anticoagulation therapy. Echocardiography and cardiac magnetic resonance were used within the diagnostic procedure and to monitor the treatment outcomes. Cardiac magnetic resonance was shown to be beneficial as it provided a more precise description of the intra-atrial masses located on the posterior left atrial wall, and in such situations, is of greater benefit than standard echocardiography. This led to the surgical removal of the intra-atrial mass; nevertheless, it was quickly followed by the recurrence of the thrombus. The anticoagulant therapy was adjusted and fortified by the introduction of acetylsalicylic acid and sequentially clopidogrel, but this also did not resolve the thrombus formation. Finally, employing a combination of rivaroxaban and clopidogrel resulted in partial thrombus regression. Therefore, various pathophysiological aspects of thrombus formation and used anticoagulation strategies are discussed. Conclusions We describe a unique case of a recurrent thrombus located on the posterior wall of the gigantic left atrium. Cardiac magnetic resonance was shown to be beneficial in providing a more precise description of the intra-atrial masses located on the posterior left atrial wall as compared to standard echocardiographic examination. Development of a thrombus after mitral valve surgery despite effective anticoagulant therapy and its final resolution by introducing a combination of rivaroxaban and clopidogrel highlights the complex etiopathogenesis of thrombus formation. This supports the potential use of this combination in tailoring an individual personalized therapy for patients with recurrent atrial thrombi.
PrintDisplayed: 22/7/2024 06:25